ATE249841T1 - Immunogene zubereitungen - Google Patents

Immunogene zubereitungen

Info

Publication number
ATE249841T1
ATE249841T1 AT95936690T AT95936690T ATE249841T1 AT E249841 T1 ATE249841 T1 AT E249841T1 AT 95936690 T AT95936690 T AT 95936690T AT 95936690 T AT95936690 T AT 95936690T AT E249841 T1 ATE249841 T1 AT E249841T1
Authority
AT
Austria
Prior art keywords
immunogenic preparations
immunogenic composition
immunogenic
preparations
solubilised
Prior art date
Application number
AT95936690T
Other languages
English (en)
Inventor
Roger Randal Charles New
Gardens
Original Assignee
Vaxcine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxcine Ltd filed Critical Vaxcine Ltd
Application granted granted Critical
Publication of ATE249841T1 publication Critical patent/ATE249841T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95936690T 1994-11-15 1995-11-14 Immunogene zubereitungen ATE249841T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions
PCT/GB1995/002675 WO1996014871A1 (en) 1994-11-15 1995-11-14 Immunogenic compositions

Publications (1)

Publication Number Publication Date
ATE249841T1 true ATE249841T1 (de) 2003-10-15

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95936690T ATE249841T1 (de) 1994-11-15 1995-11-14 Immunogene zubereitungen

Country Status (19)

Country Link
EP (1) EP0792165B1 (de)
JP (1) JP4297515B2 (de)
KR (1) KR970706848A (de)
CN (1) CN100346828C (de)
AT (1) ATE249841T1 (de)
AU (1) AU700910B2 (de)
CA (1) CA2205083A1 (de)
DE (1) DE69531793T2 (de)
DK (1) DK0792165T3 (de)
ES (1) ES2210318T3 (de)
FI (1) FI972054L (de)
GB (1) GB9422990D0 (de)
IL (1) IL116010A0 (de)
MX (1) MX9703480A (de)
NO (1) NO972219L (de)
NZ (1) NZ295238A (de)
PT (1) PT792165E (de)
WO (1) WO1996014871A1 (de)
ZA (1) ZA959729B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
AR013202A1 (es) * 1997-07-10 2000-12-13 Biotech Australia Pty Ltd Vacunas no acuosas
JP2002502884A (ja) * 1998-02-12 2002-01-29 アメリカン・サイアナミド・カンパニー インターロイキン−１２および単純ヘルペスウイルス抗原を含んでなるワクチン
IL137809A0 (en) * 1998-02-12 2001-10-31 American Cyanamid Co Pneumococcal and meningococcal vaccines formulated with interleukin-12
EP1053016A2 (de) * 1998-02-12 2000-11-22 American Cyanamid Company Interleukin-12 und respiratory-syncytial-virusantigene enthaltende impfstoffe
NZ508013A (en) 1998-05-07 2003-08-29 Corixa Corp Adjuvant composition for use with an antigen in a vaccine composition
KR100628007B1 (ko) 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
CN106310293A (zh) 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
CA2700828C (en) * 2007-10-03 2017-01-24 Immunovaccine Technologies Inc. Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
WO2009146523A1 (en) 2008-06-05 2009-12-10 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
EP2654782A4 (de) * 2010-12-23 2015-03-25 Immport Therapeutics Inc Verfahren und zusammensetzungen aus proteinantigenen zur diagnose und behandlung von toxoplasma-gondii-infektionen und toxoplasmose
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
CN113876945A (zh) 2011-10-06 2022-01-04 免疫疫苗技术有限公司 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
ATE233547T1 (de) * 1991-06-26 2003-03-15 Yamanouchi Europ Bv Vesiculae in nichtpolaren medien
EP0815852A1 (de) * 1993-08-06 1998-01-07 Opperbas Holding B.V. Verfahren zur Hochbeladung von Vesikeln mit Biopolymeren
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
KR970706848A (ko) 1997-12-01
CN100346828C (zh) 2007-11-07
ZA959729B (en) 1997-05-15
DE69531793T2 (de) 2004-07-15
IL116010A0 (en) 1996-01-31
PT792165E (pt) 2004-02-27
EP0792165A1 (de) 1997-09-03
FI972054A7 (fi) 1997-05-14
CA2205083A1 (en) 1996-05-23
FI972054A0 (fi) 1997-05-14
AU3853495A (en) 1996-06-06
NZ295238A (en) 1999-01-28
FI972054L (fi) 1997-05-14
MX9703480A (es) 1997-08-30
NO972219D0 (no) 1997-05-14
NO972219L (no) 1997-07-11
GB9422990D0 (en) 1995-01-04
JP4297515B2 (ja) 2009-07-15
DK0792165T3 (da) 2004-01-05
DE69531793D1 (de) 2003-10-23
WO1996014871A1 (en) 1996-05-23
ES2210318T3 (es) 2004-07-01
JPH10508834A (ja) 1998-09-02
AU700910B2 (en) 1999-01-14
EP0792165B1 (de) 2003-09-17
CN1163575A (zh) 1997-10-29

Similar Documents

Publication Publication Date Title
DE69531793D1 (de) Immunogene zubereitungen
WO1997001640A3 (en) Vaccines against hepatitis c
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
ES2150493T3 (es) Adyuvantes para vacunas contra el virus sincitico respiratorio.
ATE229978T1 (de) Helicobacter proteine und impstoffe
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
AU3799789A (en) Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
NO892251D0 (no) Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO870212L (no) Fremgangsmaate for fremstilling av stabile nikorandilpreparater.
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
NO911065D0 (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
AU3926097A (en) Improved inactivated vaccines
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
FR2748476B1 (fr) Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant
FR2715304B1 (fr) Vaccin anti-allergique.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
RU96116250A (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней
FI873483A7 (fi) Oksiraanipseudo-oligosakkarideja, menetelmä niiden valmistamiseksi, niiden käyttö ja farmaseuttisia valmisteita.
NO901892L (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
IT8919110A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici.
NO884921D0 (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
DK98788D0 (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler
ITRM920074A0 (it) Procedimento per la preparazione di vaccini, e vaccini cosi' ottenibili.
ATE72439T1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0792165

Country of ref document: EP

REN Ceased due to non-payment of the annual fee